Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells

Journal of Affective Disorders

Volumn 195, Issue , 2016, Pages 75-81

  Zheng, Peng ^a,b,c   Fang, Zheng ^a,b,c   Xu, Xue Jiao ^a,b,c   Liu, Mei Ling ^a,b,c   Du, Xiangyu ^a,b,c   Zhang, Xiaotong ^a,b,c   Wang, Haiyang ^a,b,c   Zhou, Jingjing ^a,b,c   Xie, Peng ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING KEY LABORATORY OF NEUROBIOLOGY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BENZOIC ACID; BIOLOGICAL MARKER; CREATININE; DOPAMINE; ETHANOLAMINE; FUMARIC ACID; GAMMA TOCOPHEROL; HOMOSERINE; HYDROXYLAMINE; ISOLEUCINE; LANOSTEROL; MALIC ACID; MALONIC ACID; NEUROTRANSMITTER; OCTANOIC ACID; RIBULOSE PHOSPHATE; SORBITOL; VALINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA TOCOPHEROL;

ADULT; AMINO ACID METABOLISM; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; HUMAN CELL; LABORATORY TEST; LIPID METABOLISM; MAJOR DEPRESSION; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; BLOOD; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; METABOLISM; MONONUCLEAR CELL; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; ALPHA-TOCOPHEROL; ANIMALS; BIOMARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METABOLOMICS; NEUROTRANSMITTER AGENTS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY;

EID: 84957796421     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.02.008     Document Type: Article

References (41)

1. J.A. Bilello, L.M. Thurmond, K.M. Smith, B. Pi, R. Rubin, S.M. Wright, F. Taub, M.E. Henry, R.C. Shelton, and G.I. Papakostas MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder J. Clin. Psychiatry 76 2015 e199 e206
2. A.P. Bradley The use of the area under the ROC curve in the evaluation of machine learning algorithms Pattern Recognit. 30 1997 1145 1159
3. M. Bylesjö, M. Rantalainen, O. Cloarec, J.K. Nicholson, E. Holmes, and J. Trygg OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification J. Chemom. 20 2006 341 351
4. J.-J. Chen, C.-J. Zhou, Z. Liu, Y.-Y. Fu, P. Zheng, D.-Y. Yang, Q. Li, J. Mu, Y.-D. Wei, and J.-j Zhou Divergent urinary metabolic phenotypes between major depressive disorder and bipolar disorder identified by a combined GC-MS and NMR spectroscopic metabonomic approach J. Proteom. Res. 14 2015 3382 3389
5. E.J. Gardiner, M.J. Cairns, B. Liu, N.J. Beveridge, V. Carr, B. Kelly, R.J. Scott, and P.A. Tooney Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral Blood mononuclear cells J. Psychiatr. Res. 47 2013 425 437
6. G. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery Metabolomics-based methods for early disease diagnostics Expert Rev. Mol. Diagn. 8 2008 617 633
7. Y. He, Z. Yu, I. Giegling, L. Xie, A.M. Hartmann, C. Prehn, J. Adamski, R. Kahn, Y. Li, T. Illig, R. Wang-Sattler, and D. Rujescu Schizophrenia shows a unique metabolomics signature in plasma Transl. Psychiatry 2 2012 e149
8. I. Holma, K. Holma, T. Melartin, H. Rytsälä, and E. Isometsä A 5-year prospective study of predictors for disability pension among patients with major depressive disorder Acta Psychiatr. Scand. 125 2012 325 334
9. Y. Jung, J. Lee, J. Kwon, K.S. Lee, D.H. Ryu, and G.S. Hwang Discrimination of the geographical origin of beef by 1H NMR-based metabolomics J. Agric. Food Chem. 13 2010 10458 10466
10. S. Koike, M. Bundo, K. Iwamoto, M. Suga, H. Kuwabara, Y. Ohashi, K. Shinoda, Y. Takano, N. Iwashiro, Y. Satomura, T. Nagai, T. Natsubori, M. Tada, H. Yamasue, and K. Kasai A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight Mass spectrometry study Transl. Psychiatry 4 2014 e379
11. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894
12. C.C. Liew, J. Ma, H.C. Tang, R. Zheng, and A.A. Dempsey The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool J. Lab. Clin. Med. 147 2006 126 132
13. M.-L. Liu, P. Zheng, Z. Liu, Y. Xu, J. Mu, J. Guo, T. Huang, H.-Q. Meng, and P. Xie GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral Blood mononuclear cells Mol. BioSyst. 10 2014 2398 2406
14. M.L. Liu, P. Zheng, Z. Liu, Y. Xu, J. Mu, J. Guo, T. Huang, H.Q. Meng, and P. Xie GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral Blood mononuclear cells Mol. BioSyst. 10 2014 2398 2406
15. X. Liu, P. Zheng, X. Zhao, Y. Zhang, C. Hu, J. Li, J. Zhao, J. Zhou, P. Xie, and G. Xu Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry J. Proteom. Res. 14 2015 2322 2330
16. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J.L. Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
17. S. Mahadevan, S.L. Shah, T.J. Marrie, and C.M. Slupsky Analysis of metabolomic data using support vector machines Anal. Chem. 80 2008 7562 7570
18. H.G. Maxeiner, M.T. Rojewski, A. Schmitt, H. Tumani, K. Bechter, and M. Schmitt Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders Brain Behav. Immun. 23 2009 134 142
19. J.H. Meyer, H.E. McNeely, S. Sagrati, A. Boovariwala, K. Martin, N.P.L. Verhoeff, A.A. Wilson, and S. Houle Elevated putamen D 2 receptor binding potential in major depression with motor retardation: an [11C] raclopride positron emission tomography study Am. J. Psychiatry 163 2006 1594 1602
20. A.J. Mitchell, A. Vaze, and S. Rao Clinical diagnosis of depression in primary care: a meta-analysis Lancet 374 2009 609 619
21. J.K. Nicholson, and J.C. Lindon Systems biology: metabonomics Nature 455 2008 1054 1056
22. J.K. Nicholson, J.C. Lindon, and E. Holmes 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1999 1181 1189
23. G. Nikisch, P. Baumann, B. Kiessling, M. Reinert, G. Wiedemann, J. Kehr, A.A. Mathé, M. Piel, F. Roesch, H. Weisser, P. Schneider, and A.J Hertel Retraction notice to "Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine" J. Psychiatr. Res. 44 12 2010 754 759
24. G. Papakostas, R. Shelton, G. Kinrys, M. Henry, B. Bakow, S. Lipkin, B. Pi, L. Thurmond, and J. Bilello Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study Mol. Psychiatry 18 2013 332 339
25. P. Proitsi, M. Kim, L. Whiley, M. Pritchard, R. Leung, H. Soininen, I. Kloszewska, P. Mecocci, M. Tsolaki, B. Vellas, P. Sham, S. Lovestone, J.F. Powell, R.J. Dobson, and C. Legido-Quigley Plasma lipidomics analysis finds long chain cholesteryl esters to BE associated with Alzheimer's disease Transl. Psychiatry 5 2015 e494
26. Y. Qi, P. Li, Y. Zhang, L. Cui, Z. Guo, G. Xie, M. Su, X. Li, X. Zheng, and Y. Qiu Urinary metabolite markers of precocious puberty Mol. Cell. Proteom. 11 2011 M111.011072
27. B. Rollins, M.V. Martin, L. Morgan, and M.P. Vawter Analysis of whole genome biomarker expression in blood and brain Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 153 2010 919 936
28. Sanacora, G., Mason, G.F., Rothman, D.L., Hyder, F., Ciarcia, J.J., Ostroff, R.B., Berman, R.M., Krystal, J.H., 2003. Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT, vol. 163, pp. 577-579.
29. G. Sanacora, G.F. Mason, D.L. Rothman, and J.H. Krystal Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors Am. J. Psychiatry 159 2002 663 665
30. Segal, D.L., 2010. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Corsini Encyclopedia of Psychology.
31. W.-H. Shao, S.-H. Fan, Y. Lei, G.-E. Yao, J.-J. Chen, J. Zhou, H.-B. Xu, H.-P. Liu, B. Wu, and P. Zheng Metabolomic identification of molecular changes associated with stress resilience in the chronic mild stress rat model of depression Metabolomics 9 2013 433 443
32. J. Trygg, and S. Wold Orthogonal projections to latent structures (O-PLS) J. Chemom. 16 2002 119 128
33. B.R. Underwood, D. Broadhurst, W.B. Dunn, D.I. Ellis, A.W. Michell, C. Vacher, D.E. Mosedale, D.B. Kell, R.A. Barker, and D.J. Grainger Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles Brain 129 2006 877 886
34. J.B.W. Williams A structured interview guide for the Hamilton depression rating scale Arch. Gen. Psychiatry 45 1988 742
35. H.B. Xu, L. Fang, Z.C. Hu, Y.C. Chen, J.J. Chen, F.F. Li, J. Lu, J. Mu, and P. Xie Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder Psychiatry Res. 200 2012 1054 1057
36. X.-J. Xu, P. Zheng, G.-P. Ren, M.-L. Liu, J. Mu, J. Guo, D. Cao, Z. Liu, H.-Q. Meng, and P. Xie 2, 4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder Mol. BioSyst. 10 2014 813 819
37. J. Yang, T. Chen, L. Sun, Z. Zhao, X. Qi, K. Zhou, Y. Cao, X. Wang, Y. Qiu, and M. Su Potential metabolite markers of schizophrenia Mol. Psychiatry 18 2011 67 78
38. P. Zheng, J.-J. Chen, T. Huang, M.-J. Wang, Y. Wang, M.-X. Dong, Y.-J. Huang, L.-K. Zhou, and P. Xie A novel urinary metabolite signature for diagnosing major depressive disorder J. Proteom. Res. 12 2013 5904 5911
39. P. Zheng, J.J. Chen, T. Huang, M.J. Wang, Y. Wang, M.X. Dong, Y.J. Huang, L.K. Zhou, and P. Xie A novel urinary metabolite signature for diagnosing major depressive disorder J. Proteom. Res. 12 2013 5904 5911
40. P. Zheng, H.C. Gao, Q. Li, W.H. Shao, M.L. Zhang, K. Cheng, D.Y. Yang, S.H. Fan, L. Chen, and L. Fang Plasma metabonomics as a novel diagnostic approach for major depressive disorder J. Proteom. Res. 11 2012 1741 1748
41. P. Zheng, Y. Wang, L. Chen, D. Yang, H. Meng, D. Zhou, J. Zhong, Y. Lei, N.D. Melgiri, and P. Xie Identification and validation of urinary metabolite biomarkers for major depressive disorder Mol. Cell. Proteom. 12 2013 207 214